News for hackers. Stuff that matters.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by crmrc114 on Tuesday December 17, 2019 @11:16AM (#21815010)
Yeah, look- I got my tests back when $99 covered everything. I got my grandparents on each side to spit in tubes for me. I was able to fill in may missing gaps in my genealogy as well as use snp-pedia to look at my own "source code". Its fun.

Guess what, my maternal granddad had Parkinson's disease. I hope to god the do something with our data. I knew that $99 was not enough to pay for the processing, storage and hosting of my data. This is the long game for 23 and me. They are a genetic research company.

I knew this was something they were going to do and I am happy they are doing it. I hope we can come up with some profitable drugs that will cure some of these more complicated disorders. Just think of what we could do if we could easily treat Alzheimer's or other age related disorders. I am not even talking about cancer or diseases like pendred syndrome that could be possible result in couples hacking nature and removing genetic illness from their kids.

I am excited. Dangers, sure. Debate, totally.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by nabdab on Tuesday December 17, 2019 @11:29AM (#21815158)
Sounds like you would give consent if asked, and I applaud you for that. Myself I gladly donate blood for free to help others. I don’t however feel that either of those willful good deeds should be viewed as arguments supporting that people should have their blood extracted or data sold without consent.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by DangerousPie on Tuesday December 17, 2019 @12:01PM (#21815583)
23&me doesn't share data without consent. They explictly tell you that they'd like to use your data for research and ask you to opt in.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @12:03PM (#21815619)
This is false. 23andMe shares data with invested parent organisations regardless of consent, and is not required to disclose the fact because they're legally not 3rd parties.

See https://news.ycombinator.com/reply?id=21815295&goto=item%3Fi...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Tuesday December 17, 2019 @04:23PM (#21818995)
Here's the 23&Me Research Consent doc that you agree to: https://www.23andme.com/about/consent/

Is there something specifically missing from that? it seems like you're suggesting they are doing somethign which is not covered here, or they're trying to be "sneaky", but I don't think that's the case. They have always made it fairly clear what the long game is, and "collect genetic information and share it with legitimate researchers to enable drug discovery" was a major part of it.

I see a lot of folks suggesting 23&Me is being sneaky, or underhanded, or going out of its way to cloak these sorts of exchanges. I do not agree with those interpretations.

Note: I am generally sympathetic to the idea of widely sharing genomic information and believe that good consent forms are transparent. This form is closer to what I'd like to see from a wider range of less ethical organizations.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by jonas21 on Tuesday December 17, 2019 @09:02PM (#21821079)
This looks pretty good to me. First, it appears to be opt-in:

> Giving consent by checking the appropriate box below means that you agree to let 23andMe researchers use your Genetic & Self-Reported Information for 23andMe Research, as described above.

And they have a reasonable policy if you decide you want to opt out:

> At any time, you may choose to change your consent status to either take part in 23andMe Research or to withdraw all or some of your Genetic & Self-Reported Information from 23andMe Research. Your consent status is located in the 23andMe "Settings" page. ...

Choosing not to give consent or withdrawing from 23andMe Research will not affect your access to your Genetic Information or to the Personal Genome Service.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by burnte on Tuesday December 17, 2019 @01:06PM (#21816506)
Your use of their program is consent, they tell you when you get the kit.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by taneq on Tuesday December 17, 2019 @01:29PM (#21816839)
There's a pretty significant difference between "when you use their service you can opt-in to have your data added to the dataset" and "buried in the EULA is a clause saying they own your genes."
Re:23andMe to share customer gene data with GlaxoSmithKline ... by threatofrain on Tuesday December 17, 2019 @02:27PM (#21817635)
Ah I see there’s the opt in. In that case Microsoft telemetry is opt in too. You bought into Windows and agreed with the EULA after all.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Tuesday December 17, 2019 @05:13PM (#21819482)
It appears some people in this thread use a rather creative version of "opt in" [1]. There is nothing "opt" about what has been described here, nor about Microsoft telemetry (it was opt-out last time I checked).

[1] https://en.wikipedia.org/wiki/Opt-in_email

Re:23andMe to share customer gene data with GlaxoSmithKline ... by guiambros on Tuesday December 17, 2019 @11:11PM (#21821705)
Please tell me what "creative version of opt-in" you see in this: https://www.23andme.com/about/consent/

---

6. Do I have any alternatives? Can I withdraw from this study?

Your alternative is not to participate in the 23andMe Research study. If you choose not to give consent for 23andMe Research, your Genetic & Self-Reported Information may still be used for other purposes, as described in our Privacy Statement. If you do give consent to participate in this study, you may choose not to take 23andMe Research surveys or use other 23andMe Research features.

At any time, you may choose to change your consent status to either take part in 23andMe Research or to withdraw all or some of your Genetic & Self-Reported Information from 23andMe Research. Your consent status is located in the 23andMe "Settings" page (if you experience problems changing your consent status, write to the Human Protections Administrator at [email protected]). If you withdraw all or some of your Genetic & Self-Reported Information, 23andMe will prevent that information from being used in new 23andMe Research initiated after 30 days from receipt of your request (it may take up to 30 days to withdraw your information after you withdraw your consent). Any research on your data that has been performed or published prior to this date will not be reversed, undone, or withdrawn.

Choosing not to give consent or withdrawing from 23andMe Research will not affect your access to your Genetic Information or to the Personal Genome Service.

You may also discontinue participation by closing your Personal Genome Service account, as described in the Terms of Service. Requests for account closure can be made directly within your Account Settings.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by mikekchar on Wednesday December 18, 2019 @06:23AM (#21823829)
I don't know anything about it, but:

> Your alternative is not to participate in the 23andMe Research study. If you choose not to give consent for 23andMe Research, your Genetic & Self-Reported Information may still be used for other purposes, as described in our Privacy Statement

Seems to imply that if you do not give your consent for whatever "23andMe Research" is, then they will still use the data for other purposes. So in other words if you do not opt in they will still use they data. That's not a normal definition of "opt in".

However, I don't know what is in the privacy statement. What are they able to do with the data if you don't opt-in?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Xelbair on Wednesday December 18, 2019 @02:35AM (#21822697)
Looking as you cannot completely disable telemetry in windows 10 i fail to see how it is opt-in, or even opt-out. It is always on.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Wednesday December 18, 2019 @06:48AM (#21823941)
I don't use Windows 10, but I from what I understand Microsoft had to make it GDPR compliant. I'm not sure they succeeded entirely with that (last time I checked, the German government did not find it GDPR compliant. Regardless, at the very least it was an improvement [which isn't an excuse]).
Re:23andMe to share customer gene data with GlaxoSmithKline ... by justinclift on Wednesday December 18, 2019 @10:55AM (#21826099)
> Microsoft had to make it GDPR compliant.

Not really. It's more like they have an army of lawyers paid so they can claim GDPR compliance, and delay/suppress or negotiate deals for years (if not decades) anything that comes up to say their not.

That being said, apparently there are already ongoing legal cases around GDPR complaints for MS. No idea how those will end up.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by enkid on Tuesday December 17, 2019 @07:12PM (#21820485)
I believe that's his point
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Nullabillity on Tuesday December 17, 2019 @01:56PM (#21817219)
Consent is not freely given if it's a requirement for something else.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by dkonofalski on Tuesday December 17, 2019 @04:04PM (#21818821)
I think a clearer phrasing of that is "Consent is not freely given unless it's explicit". I'm fine with giving consent as long as I'm clear on what that is. General consent for using a service, to me, doesn't include using my data and/or information outside of what's needed to provide that service.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by wasdfff on Tuesday December 17, 2019 @02:26PM (#21817628)
Looks like every end user agreement is bs by that metric too
Re:23andMe to share customer gene data with GlaxoSmithKline ... by lovich on Tuesday December 17, 2019 @02:44PM (#21817853)
That is a legitimate argument people make and also a reason companies don't want to test their EULA's in court
Re:23andMe to share customer gene data with GlaxoSmithKline ... by delecti on Tuesday December 17, 2019 @02:45PM (#21817868)
Yes, they are. And GDPR at least seems to rather explicitly agree with that sentiment. Consent buried in a document isn't real consent.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Xelbair on Wednesday December 18, 2019 @02:37AM (#21822705)
Yeah, and you cannot 'bundle' consent.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by austhrow743 on Tuesday December 17, 2019 @08:20PM (#21820875)
Trade, no, interacting with others in general; ruled nonconsensual. You read it here first folks!
Re:23andMe to share customer gene data with GlaxoSmithKline ... by BurningFrog on Tuesday December 17, 2019 @06:48PM (#21820328)
This idea would really upend contract law if applied there!
Re:23andMe to share customer gene data with GlaxoSmithKline ... by gmanley on Tuesday December 17, 2019 @02:46PM (#21817877)
In this case it totally is. Your free to not use 23andMe if you don't consent. I do think, however, it shouldn't be buried in the EULA but communicated clearly.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Tuesday December 17, 2019 @05:16PM (#21819497)
> Your free to not use 23andMe if you don't consent

That is not how consent works.

If I am selling you an apple, but thereby you give me consent to use its genetics for research, and without that we do not do business, then there is nothing optional about it; no opt-in, no opt-out.

Opt-in is when the flag is disabled by default, and you can enable it if you want to, and use the product regardless of your choice.

Opt-out is when the flag is enabled by default, and you can disable it if you want to, and use the product regardless of your choice.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by matz1 on Tuesday December 17, 2019 @10:45PM (#21821580)
That is how consent should work, if I don't consent I should not buy your apple. Buying your apple is optional, I'm not required to buy your apple.

Opt-in is when I buy your apple.

Opt-out is when I don't buy your apple.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by misterman0 on Wednesday December 18, 2019 @01:12AM (#21822310)
You're not buying apples, though. You're buying "apples+X". That's a different from "apples". If your seller is upfront about that then I and people who want just an apple can go somewhere else for fruit. Most, though, aren't upfront about it.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by matz1 on Wednesday December 18, 2019 @09:05AM (#21824891)
If you want to buy just apples then you should buy it from other seller who just sells apples.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Wednesday December 18, 2019 @09:11AM (#21824969)
That is up to our governments to decide if such is allowed or not. For example, it isn't allowed to sell a gun or drugs with an apple (at least not here in The Netherlands, YMMV).

That you can decide to not go for the entire package is not what we disagree on (apart from above, I suppose).

What we were discussing is that the consent is optional; it is not in any of these examples. It is part of the package deal; then you don't call it opt-in or opt-out, as that allows you to opt-in or opt-out of something which is otherwise not in your direct advantage, but is in the other party's advantage.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by matz1 on Wednesday December 18, 2019 @09:24AM (#21825107)
That should be up to us (not government) to decide if such is allowed or not.

>What we were discussing is that the consent is optional

Yes the consent is optional, in the sense you are allowed to opt-out by not buying the apple or buying it from someone else or produce it yourself.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Wednesday December 18, 2019 @09:42AM (#21825281)
> That should be up to us (not government) to decide if such is allowed or not.

It is up to us to elect those who represent us in our governments.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by matz1 on Wednesday December 18, 2019 @11:52AM (#21826754)
Sure, I will elect those who allow consent as I describe.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Thursday December 19, 2019 @03:06AM (#21832946)
All in the name of "liberty" for businesses, so they can vulture on the weak (the consumer). Land of the free, indeed.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by matz1 on Thursday December 19, 2019 @03:42PM (#21839038)
Its a mutually beneficial transaction between the business and the customer.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Wednesday December 18, 2019 @04:11AM (#21823145)
Let's say there are two people who are supposed to get a punishment. One is found guilty by a fair trial, the other one is not found guilty by a fair trial.

For some superficial rule, I may only punish the person who has been found guilty by also punishing the person who has not been found guilty.

Can you explain to me how this is fair?

Here is where you and I differ. You find it OK when a party (e.g. business) uses your private data to sell or otherwise use for their benefit. I believe such personal data is ultimately my say. And I believe only informed opt-in (optional, not part of a package deal ie. how GDPR works) is a fair way to deal with such situation.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by burnte on Wednesday December 18, 2019 @02:12PM (#21828193)
> That is not how consent works.

Yes, it is. I tell you all the terms of the deal in advance, and you choose to accept it or not. If you don't want my apples, go to the next guy.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Fnoord on Thursday December 19, 2019 @03:06AM (#21832939)
I do want your apples, I don't want you to sell my personal information.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by endorphone on Tuesday December 17, 2019 @10:12PM (#21821425)
This has been claimed multiple times and it's totally untrue.

GSK is not a "parent company". It is a minor investor. This also doesn't give them some ability to demand access.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by ailideex on Tuesday December 17, 2019 @03:01PM (#21818075)
Who are 23andMe's parent companies (https://en.wikipedia.org/wiki/Parent_company)?

> In the United Kingdom, it is generally held that an organisation holding a 'controlling stake' in a company (a holding of over 51% of the stock) is in effect the de facto parent company of the firm, having overriding material influence over the held company's operations, even if no formal full takeover has been enacted.

HINTS: GSK (UK based) is not one of them.

https://www.gsk.com/media/5349/annual-report-2018.pdf

> 23andMe in which the Group holds 14.5%.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by throwaway_tech on Tuesday December 17, 2019 @12:43PM (#21816196)
>They explictly tell you that they'd like to use your data for research

Is there not a difference between using your data for research...and selling it to a pharmaceutical company attempting to develop a commercial drug?

Seems there was a misrepresentation in giving up their DNA, and those people should have rights to any drugs developed as a result.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by filoleg on Tuesday December 17, 2019 @01:10PM (#21816571)
Who do you think does most of the pharmaceutical research? According to some quickly googleable info, private funding for pharmaceuticals is about 5 times that of public NIH research [0]. And before we assume that it all goes into the executive pay, turns out that private pharma in the US reinvests more of its revenues back into research and development than any other industry in the US (according to the same source).

0. https://www.drugcostfacts.org/public-vs-private-drug-funding

Re:23andMe to share customer gene data with GlaxoSmithKline ... by _jal on Tuesday December 17, 2019 @09:58PM (#21821359)
That's a pharma trade-org PR site. To be fair, I doubt they're directly lying about anything.

But why talk about executive pay and not marketing? Research clearly takes a backseat to marketing at these shops:

https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-p...

As for who pays for research, you're right that pharma companies now pay for over half of US biomed research, something that's been true for about a decade. I don't know how that "5 times" figure was calculated, but my figures show the government currently finances about 1/3 of biomed research, including almost all basic research.

Of course, pharma benefits from that research, too, and looking only at spends understates the value of those contributions. One recent study found that

"NIH funding contributed to published research associated with every one of the 210 new drugs approved by the Food and Drug Administration from 2010–2016."

https://www.pnas.org/content/115/10/2329

Re:23andMe to share customer gene data with GlaxoSmithKline ... by throwaway_tech on Tuesday December 17, 2019 @01:46PM (#21817075)
What does that have to do with obtaining HIPPA/DNA data the way they did?

What does big pharma reinvesting more of its revenue back into R&D have anything to do with obtaining peoples DNA through any means but directly from the owners of the DNA?

Big Pharma also spends more in lobbying efforts than any other industry...in fact double the next industry (tech)...in fact they spend in lobbying what the #2 and #3 industries (tech and insurance) spend together. Were you aware big pharma lobbying goes towards R&D tax credits for themselves?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by ajoy on Tuesday December 17, 2019 @06:03PM (#21819930)
Re:23andMe to share customer gene data with GlaxoSmithKline ... by pathseeker on Tuesday December 17, 2019 @01:21PM (#21816733)
>Is there not a difference between using your data for research...and selling it to a pharmaceutical company attempting to develop a commercial drug?

No...? Precluding companies from coming up with cures for diseases based on researching this data seems to defeat one of the major points of medical research.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by throwaway_tech on Tuesday December 17, 2019 @01:47PM (#21817092)
>Precluding companies from coming up with cures for diseases based on researching this data seems to defeat one of the major points of medical research.

Since when is privacy violations a major point of medical research? Did these pharma companies get your DNA through a 3rd party without your knowledge?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Sir_Substance on Tuesday December 17, 2019 @12:46PM (#21816235)
crmrc114 shares almost all of their DNA with their parents, children, siblings and cousins, in addition to the mentioned grandparents.

I'll bet you a dollar that neither crmrc114 nor 23&me asked /all/ the stakeholders in this particular transaction for consent.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by mistersquid on Tuesday December 17, 2019 @10:44PM (#21821579)
This genetic data will be used by 3rd parties not (only?) altruistically but to maximize profits. Any products developed using this genetic data will likely have profit as their primary motive.

Wanting to accelerate the development of novel drugs and therapies to treat disease is great. But rather than giving a private company carte blanche to share data with third parties trusting (hoping?) that the outcome will benefit humanity, it would be better first to establish a sensible regulatory framework around genetic information and its uses by private companies and the governnment.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by marticode on Wednesday December 18, 2019 @12:00AM (#21821953)
If curing and saving people has the side effect of some company making money, I think I can live with that.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by raven105x on Wednesday December 18, 2019 @12:26AM (#21822089)
Saving people is extremely profitable - curing, however, is anything but.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by roenxi on Wednesday December 18, 2019 @01:45AM (#21822445)
Curing people is still profitable. If you are competing with an incumbent who only treats symptoms you can claim their business by curing patients.

Unless somehow it were possible to gain a monopoly on curing people, which is plausible but fundamentally not the responsibility of the researchers.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by kevingadd on Wednesday December 18, 2019 @01:49AM (#21822472)
Have you heard of patents? For-profit pharmaceutical companies use them to establish a monopoly on drugs they develop.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by kungito on Wednesday December 18, 2019 @06:13AM (#21823786)
Patents last 20 years, humanity existed for thousands. We can wait 100 more years for cures if it's the optimal way
Re:23andMe to share customer gene data with GlaxoSmithKline ... by autoexec on Wednesday December 18, 2019 @06:48PM (#21830712)
The drug companies have a solution to patent limits called "evergreening" where once a patent is about to expire they make a very slight modification to the formula, pump massive amounts of cash into marketing it as "new and better" even when there are little to no benefits over the old formula. Doctors are easily bribed or mislead into prescribing the expensive new formula over generics and drug companies can continue to make large profits on old drugs instead of innovating.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by killjoywashere on Tuesday December 17, 2019 @11:14PM (#21821724)
> it would be better first to establish a sensible regulatory framework

The new common rule provides for just such a thing called broad consent, which requires tracking patient consent in a fine-grained and revokable way. Interestingly, about the time it came into effect, I heard about a new start-up supported by George Church, called Nebula, which provides just such a consent service using a blockchain.

So, the regulatory framework exists, and a product to implement that is on the market. And this stuff was in discussion for better part of a decade, so it's not like this just snuck up on people.

https://blog.nebula.org/anonymous-sequencing/

Re:23andMe to share customer gene data with GlaxoSmithKline ... by travisoneill1 on Tuesday December 17, 2019 @11:26PM (#21821793)
Of course their motive is not altruistic, and what does it matter anyway? They won't make money if the outcome of the research isn't beneficial. What use would a bunch of government bureaucracy be?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by gowld on Wednesday December 18, 2019 @12:43AM (#21822172)
amp.cnn.com/cnn/2019/12/17/us/purdue-pharma-sackler-family-10-billion-withdrawals/index.html
Re:23andMe to share customer gene data with GlaxoSmithKline ... by alexfromapex on Tuesday December 17, 2019 @10:45PM (#21821585)
Can’t upvote this enough
Re:23andMe to share customer gene data with GlaxoSmithKline ... by rawoke083600 on Wednesday December 18, 2019 @01:18AM (#21822329)
That's fine ! I'd probably get a better drug if the primary motive was profit rather than just "we care"...
Re:23andMe to share customer gene data with GlaxoSmithKline ... by malandrew on Wednesday December 18, 2019 @01:20AM (#21822336)
Only someone who either doesn't have a treatable disease themself or doesn't have a family member who does could think this way.

I have a medical issue with no cure and so does my dad. My mother died from cancer a few years ago. I could care less if they make a profit or not so long as it improves my quality of life and that of my father.

For much of my mother's treatment, both the first time she got cancer (and beat it) and the second time (when she did not), she was getting treatment that only existed in the US. Why? Because it's profitable here.

I myself take an orphan drug only available in the US and only developed because of changes like the Orphan Drug Act of 1983.

Altruism is fine and good, but profit-seeking is more effective and expedient.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by vallode on Wednesday December 18, 2019 @05:46AM (#21823651)
I could similarly say only a person with a treatable illness who can afford said for-profit drugs thinks this way. 'profit-seeking is more effective and expedient' for the people that can afford it...
Re:23andMe to share customer gene data with GlaxoSmithKline ... by malandrew on Wednesday December 18, 2019 @12:42PM (#21827268)
> 'profit-seeking is more effective and expedient' for the people that can afford it

It doesn't matter if you can afford everything in the world if the thing you need is never developed in the first place.

Some of the treatments me and my family have had were not available in Europe, Canada and other universal healthcare countries at any price. I would have probably lost almost two decades of time that I got to spend with my mother because she got treatment in the US the first time she got cancer. She was British and at the time the NHS had the 2nd worst success rates for cancer of all OECD countries and the US had the highest success rates.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by yostrovs on Wednesday December 18, 2019 @07:07AM (#21824036)
Only one secure and wealthy enough has the time and interest discussing matters like this. The poor and downtrodden don't even participate in these debates. Your privilege is getting ahead of you.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by drusepth on Tuesday December 17, 2019 @02:54PM (#21817980)
I'm really shocked at some of the responses you're getting. I'm in a similar situation, except for Alzheimer's. I signed up to 23andme (and several other genome companies) explicitly to give them more data for their research. The product was kind of cool (I connected my mom with a long-lost brother!) but the real product is research and what comes from that research.

There are dangers if it's misused, sure, but the benefits for literally everyone on the planet dwarfs even the worst, least-likely dangers, IMO.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dpcan on Tuesday December 17, 2019 @03:39PM (#21818535)
Sorry, but this is the classic "I have nothing to hide" argument in regards to privacy.

If they want to market their services as "donate your DNA for research" and then, as a side-note, we'll send you back some fun details about you... Fine. But right now, they sell it as a way to know about yourself, your family, genes, etc. Then millions of people wake up to the news to find out that their DNA was handed over to a pharma company.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by drusepth on Tuesday December 17, 2019 @03:51PM (#21818675)
It shouldn't be controversial to say that I value everyone on the planet having a higher quality of life more than I value a small subset of people's worry over losing privacy to a company that they not only willingly gave their DNA to, but also opted in during the signup process to use that DNA for health research.

If they feel fooled for whatever reason (I assume because that research is being done by another company instead of 23andme directly) and are now claiming they've lost some semblance of privacy over deidentified data they already handed over, that pales in comparison to lifesaving cures that are enabled and made more likely by sharing such data.

Quality of life for everyone > pedantics of what exact things you're opting into when you give your DNA to a genetic research company that dedicates a whole page in the signup flow to using your DNA for lifesaving research and cures.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Faark on Tuesday December 17, 2019 @04:20PM (#21818965)
How kind of you to make this decision for all of your relatives. They now better take care to not leave any DNA traces when protesting against some upcoming authoritarian government. And no, those databases won't be deleted before a wannabe-king takes over.

Or when signing up for health insurance a policy chain down the road. At that point the new treatment better be cheap enough to pay out of pocket...

But seriously, how can you in good conscious claim this all being willingly when it's very nature shares info about other people as well. This feels like unaware people giving Facebook access to their phone book all over again, thus giving away all kinds of info about me. No, I don't want FB creating shadow profiles about me and certainly wasn't asked.

Can we please find a way to not create piles of data about third parties? Since, if history has shown one thing, them being used against me is just a matter of time. Or, at least have in place strong protections by e.g. regulations?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Tuesday December 17, 2019 @05:52PM (#21819846)
drusepth's relatives don't own drusepth's DNA. This would be similar to arguing that if I had an identical twin, I need my twin's consent to donate a photo of myself to a facial recognition library.

But more generally, the arguments being raised here regarding risk of abuse of the data are predicated on tyrannical or illegal activities occurring. Instead of denying ourselves the benefits of cures derived from data such as this, why can we not build a society where the data is not abused?

Human pro-social activity is a very powerful thing. If there are risks in unifying data, we should work to build a society that stewards those risks responsibly, we shouldn't try to cut ourselves off and hope the life of a data hermit serves us better.

I mean, what other technologies should we deny ourselves? A tyrant can use tanks and troop transports to wage war on their citizens. Should we tear up the roads lest they be abused by tyranny?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by austhrow743 on Tuesday December 17, 2019 @08:29PM (#21820920)
> drusepth's relatives don't own drusepth's DNA.

This doesn't preclude drusepth from using their property in an assholish way.

>This would be similar to arguing that if I had an identical twin, I need my twin's consent to donate a photo of myself to a facial recognition library.

No, it'd just mean that you're an asshole if you do.

>But more generally, the arguments being raised here regarding risk of abuse of the data are predicated on tyrannical or illegal activities occurring. Instead of denying ourselves the benefits of cures derived from data such as this, why can we not build a society where the data is not abused?

Time scale. Societies come and go. To the extent that we don't have tyrannical ones they're not exactly long lived. Once you've given the data and power to the non-tyrannical government, you're screwed if tyranny ever swings around again. That's a huge gamble to make off of nothing given the history of all world governments. Seems far more likely they'll all be tyrannical again at some point than never again ever.

>I mean, what other technologies should we deny ourselves?

All of them. Technology is a perversion of our innate condition. A result of mate signalling gone off the rails.

>A tyrant can use tanks and troop transports to wage war on their citizens. Should we tear up the roads lest they be abused by tyranny?

Of course!

Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @09:29AM (#21825151)
We will, of course, skip the irony that you can only share those thoughts with us via a technology that a tyrant could abuse.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by asah on Tuesday December 17, 2019 @08:18PM (#21820865)
This is actually an interesting debate and suggests that individual consent isn't the ideal mechanism for DNA sharing vs (say) government regulation.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @11:07AM (#21826241)
I agree, but it's hard to establish good regulation in a space where society hasn't yet come to some consensus on the underlying philosophy that would guide such regulation, is the problem.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by johnnycab on Wednesday December 18, 2019 @10:29AM (#21825800)
>I mean, what other technologies should we deny ourselves? A tyrant can use tanks and troop transports to wage war on their citizens. Should we tear up the roads lest they be abused by tyranny?

As you have been overly fond of using tu quoque as a rhetorical device throughout this thread ─ in your earlier response, you trivialised the exercise of willingly handing-over the most precious of all and the pinnacle of personal data, whilst paying for the privilege, and compared it to just another transaction on Amazon: what about the fact, that almost all tyrants are enabled and empowered by somebody (usually the govt.); it would be conducive to conclude based upon your fervour, that you are equally complicit in creating yet another tyrannical corporation, which shares your disdain for privacy?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @11:01AM (#21826166)
Your conclusion begs the question that the corporation in question is tyrannical or disdains privacy. Apart from that, I'll absolutely own that I want to see them succeed; I believe in the likelihood that big-data analysis is a valuable tool in conquering the diseases that have been resistant to past methods of devising cures. I volunteered my DNA for this purpose (and none of the DNA that 23andme holds wasn't volunteered for this purpose).
Re:23andMe to share customer gene data with GlaxoSmithKline ... by johnnycab on Wednesday December 18, 2019 @02:27PM (#21828339)
>Your conclusion begs the question that the corporation in question is tyrannical or disdains privacy

If you seek an answer to that question, you don't have to venture very far from Google, who birthed this creation.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @03:56PM (#21829354)
I don't seek an answer, because I believe the question is answered that 23andme is not tyrannical and doesn't disdain privacy. Neither does Google, for that matter, and I think many people agree with such an assessment (Gmail has nearly half a billion active users).

"Begs the question" means your argument presupposed the truth of this part of the statement instead of supporting it.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dkonofalski on Tuesday December 17, 2019 @04:11PM (#21818884)
>but also opted in during the signup process to use that DNA for health research.

That is not the same thing as selling data to third-parties. Especially considering that 23andMe asks users questions and then shows results based on correlations, it's too easy for users to understand "opting in for health research" as research being done by 23andMe and not by a third-party.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by badrabbit on Tuesday December 17, 2019 @09:07PM (#21821102)
I don't get it, are you being naive or ignorant? Are you not aware of how much genetic science and ML have already been abused in the past? Are you also not aware of how much the laws and public understanding of the techs and their implications is severely lacking? Cure parkinsons but hey systemic eugenics no big deal? I mean,come on...we live in quite the evil world with all sorts of people that will gladly misuse this data and the tech to make inference out of it.

I am all for finding cures but the unwitting public needs to be protected. Most people assume there is no way a legit company would do something terribly evil.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by wahern on Tuesday December 17, 2019 @10:09PM (#21821412)
> Most people assume there is no way a legit company would do something terribly evil.

Are you kidding? Cynicism is endemic in the U.S. today; likewise for anti-corporatism. You can see it in the comments.

Personally, I'm in the same boat as the OP: I was a very early 23&Me customer and persuaded many family members to also participate, with the knowledge that 23&Me would monetize the data through research. They never claimed to be a non-profit. They were relatively transparent about their opt-in and opt-out policies, though after the FDA debacle their "simplified" website became significantly more complex and opaque. I also participated in a Kaiser Permanente whole genome sequencing research program, donated my blood samples, and then never heard anything ever again. I hope they're doing good science, especially because donating my whole genome is significantly more invasive from a privacy perspective than a few thousand SNPs.

If we sat around and waited for the perfect environment that addressed everybody's concerns, we'll be waiting forever. In the meantime, the less selfish among us are putting our own privacy at risk for the greater good. And the more of us that do that, the more political pressure there will be to sustain and expand existing legal protections prohibiting discrimination.

Not only am I glad 23&Me is selling the data (and this isn't the first time), I hope that overtime they'll have enough income that they can start sharing much of their data for free with schools and labs around the world. The latter may never come to pass, but I can't let perfection be the enemy of the good. And I won't let fear and uncertainty turn me into a perpetual privacy victim.

EDIT: I just received an e-mail from KP regarding their research project. It's the first I've noticed, but judging by my e-mail log they seem to have sent a handful over the past several years which I apparently deleted as spam. Here's the project website: https://researchbank.kaiserpermanente.org/

Re:23andMe to share customer gene data with GlaxoSmithKline ... by badrabbit on Wednesday December 18, 2019 @01:43AM (#21822436)
I am not kidding. Only a subset of college educated people have that cynicism

> If we sat around and waited for the perfect environment that addressed everybody's concerns, we'll be waiting forever.

Forever sounds better than the alternative. You seem so eager to sacrifice so much on the altar of hope based on wishful thinking that this data will not be abused. The #1 rule in technology should be "if it can be abused,it will be abused" there are no exceptions to this.

Like another commenter suggested,perhaps your current place in society has you free from such fears but rest assured that in times of war,turmoil or civil conflict or when spy agencies and the military want to gain an operational advantage using this tech/data It will be used against you. Your sick and disabled family members would have been subject to eugenics. It's not difficult to imagine any social group finding themselves in a position of weakness against a hostile power,group or individual. Look at all the horrible experiments the CIA performed, euegenics by usgov/army, the horrible things they did in Iraq and cia detention facilities,etc... the typical situation imho will be a cooperation between evil government and these companies where the companies abuse the data/tech with impunity in exchange for sharing access with their gov protectors.

Just take a peek at all the inhumanity and amorality of the pharmaceutical industry's greedy price hikes/rigging. Do you still think these are trustworthy people who won't take every opportunity to profit and say "sorry" when they get caught? (Or just bribe politicians and ignore the whole thing).

I mean how naive and deluded are you? I still don't get you and op's state of mind here. Horrible abuses will happen at large scales, guaranteed (not even speculating)!

Re:23andMe to share customer gene data with GlaxoSmithKline ... by LunaSea on Wednesday December 18, 2019 @09:15AM (#21825006)
> In the meantime, the less selfish among us are putting our own privacy at risk for the greater good.

Your actions are actually more selfish. You have an opinion where you don't care about other people's opinion, so that's selfish.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by gowld on Wednesday December 18, 2019 @12:48AM (#21822205)
People with the same skin color and religion as the economic and political elites tend to not need to worry about eugenocide.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by badrabbit on Wednesday December 18, 2019 @01:45AM (#21822449)
Yeah, false sense of security. It takes a day for a well built system to collapse (and your position in it as well).
Re:23andMe to share customer gene data with GlaxoSmithKline ... by hrktb on Tuesday December 17, 2019 @11:43AM (#21815348)
How do you see the risk of the most greedy company bidding the most to get privileged access to the data, and coming up with a cure that out-prices you or your family if you ever end up hit by the disease ?

For me this is the simulation that gives me pause. I also guess that research might not just happen on itself, but can't help to wonder what better ways they could be to avoid getting cornered at the end.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by drusepth on Tuesday December 17, 2019 @07:39PM (#21820680)
>How do you see the risk of the most greedy company bidding the most to get privileged access to the data, and coming up with a cure that out-prices you or your family if you ever end up hit by the disease?

Is that preferable to an alternative where no company can bid on such data, and therefore a cure either never exists or is delayed N years (where N is probably significant)?

Consider also that all medicine often starts prohibitively expensive to offset R&D, and predictably lowers in cost over time.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by gowld on Wednesday December 18, 2019 @12:51AM (#21822219)
"Mylan now offers the authorized generic for Epipen for roughly $150 to $350 for a two-pack" (which expires after 1 year.)
Re:23andMe to share customer gene data with GlaxoSmithKline ... by delfinom on Tuesday December 17, 2019 @03:47PM (#21818640)
>Guess what, my maternal granddad had Parkinson's disease. I hope to god the do something with our data. I knew that $99 was not enough to pay for the processing, storage and hosting of my data. This is the long game for 23 and me. They are a genetic research company.

Sadly because of the state of America, your insurance company once it gets your genetic data is going to make you sorely regret it.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Tuesday December 17, 2019 @04:12PM (#21818895)
it's illegal for health insurers to discriminate using genetic information: https://www.genome.gov/about-genomics/policy-issues/Genetic-... ("Specifically, health insurers may not use genetic information to make eligibility, coverage, underwriting or premium-setting decisions").
Re:23andMe to share customer gene data with GlaxoSmithKline ... by lostcolony on Tuesday December 17, 2019 @05:24PM (#21819581)
Currently it is. That can change.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Tuesday December 17, 2019 @06:08PM (#21819967)
Sure, but it's a law, and any change like that would be major national news, debated extensively in Congress, and then, if turned into a new law, would roll out over years.

And it's unlikely it would be passed as a law, because (currently) most people favor privacy for their genomic information.

Personally, I can see the value in allowing health insurance to access genomic information. Assuming it truly correlates with health outcomes, the data would be valuable in accurately personalizing contracts. I believe other indicators are already used.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Tuesday December 17, 2019 @06:25PM (#21820128)
Like net neutrality?

There can easily be a hole punched in the law with some weasel words in an omnibus bill that nobody pays attention to until 5 years later and we are hearing about the problems in a 60 minutes exclusive.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by LanceH on Tuesday December 17, 2019 @08:06PM (#21820812)
So if things were different, they would be different.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Tuesday December 17, 2019 @11:30PM (#21821815)
What value are you adding with this meaningless comment?

I was refuting the parent’s point:

“any change like that would be major national news, debated extensively in Congress, and then, if turned into a new law, would roll out over years.

Which is manifestly false for the reasons I outlined.

Are you suggesting otherwise?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Wednesday December 18, 2019 @10:46AM (#21826000)
The problem is you gave a single anecdotal example, and there was a bunch of attention paid at the time anyway and lots of people complained.

You can't insert major changes to health laws in omnibus spending bills.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Wednesday December 18, 2019 @10:58AM (#21826146)
There is nothing anecdotal about it, since it is a fact.

Almost nobody complained, there was no meaningful mainstream coverage, and most people don’t even know there was a change even now.

And you don’t need to insert a major change to punch a hole in the law. A small exception will do it.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Wednesday December 18, 2019 @11:01AM (#21826165)
Personalized contracts means no more spreading of risk, which completely negates the value of insurance companies.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by Sevrene on Tuesday December 17, 2019 @09:23PM (#21821185)
Here in Australia it's not illegal for life insurance, but they've just brought in a morutorium before deciding if they're going to keep allowing it to be legal, so that could change.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by wahern on Tuesday December 17, 2019 @10:37PM (#21821538)
It's problematic for life insurance. You can socialize the costs of the self-selection problem in healthcare, but you can't do the same with life insurance. Maybe at the margins we can tweak things, provide publicly-funded alternatives (e.g. like Social Security survivorship benefits in the U.S.), etc but fundamentally if you prevent discrimination then private life insurance will simply disappear.

When I bought my term life insurance policy they took a blood sample, as they have for decades. I don't know if they did any genetic screening, but if they didn't I presume it's just because the cost+benefit wasn't there yet. Considering that I could do whole genome sequencing today for a couple thousand dollars and game the system, that bodes well for the future as it suggests the viability of tiered screening and risk management strategies that smooth out the costs for most people in the face of increasing self-selection behaviors as genome sequencing costs decline for insurer and insured.

BTW, regardless of whether a life insurer does genetic screening, if you procure a policy knowing of a substantial risk of genetic illness without disclosing it that would violate the terms of most policies and may even rise to the level of insurance fraud.[1] We may see laws limiting the types of affirmative screening that can be done by insurers, but I could never see a law limiting such contractual terms and general background rules as it would certainly destroy the market for life insurance.

[1] Thus, if you want both life or disability insurance and genetic tests, the legally and ethically correct thing to do is buy the policy first and then do the genetic tests afterwards. It makes sense to buy life and disability insurance at a relatively young age, anyhow, like in your late twenties or early thirties where your income has [hopefully] already risen to a level where you can buy a multi-million dollar policy without a penalty--from a risk management perspective insurers can only offer the best rates when there's a correspondence between the policy amount and existing, proven income. By contrast, it makes less sense to do genetic testing until you have reason to, like in middle age. That's fortuitous and one reason why we should be less concerned about the effect of voluntary genetic testing and disclosure rules regarding life insurance. (Obviously affirmative genetic screening is a different problem.)

Re:23andMe to share customer gene data with GlaxoSmithKline ... by m463 on Tuesday December 17, 2019 @06:08PM (#21819975)
Would it be legal to use genetic information in advertising?

For example, advertise only to healthy people?

I think about how new privacy laws prohibit "selling" of advertising data, but there's nothing about just "sharing".

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Tuesday December 17, 2019 @06:14PM (#21820027)
I don't know enough about the law to say whether this is legal, but I believe correlates of genetic information are already used in advertising.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by seganddr on Tuesday December 17, 2019 @08:08PM (#21820819)
It's interesting for a new account to have such a strongly opinioned, eloquent, and top voted comment on such a controversial topic.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by peu4000 on Tuesday December 17, 2019 @09:35PM (#21821239)
Do you find it similarly interesting that a 5 year old account with 3 other posts and a few comments posted a 1.5 year old article and managed to get over 300 upvotes on it?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by seganddr on Wednesday December 18, 2019 @05:55PM (#21830333)
I had never considered those metrics as a possible source of data. I'll have to think about it. Thank you.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by trianglem on Tuesday December 17, 2019 @02:03PM (#21817324)
This is why when I sent in my sample I used a fake name and a disposable debit card for the purchase. I also got it back when it was $99 without a subscription and I hope those steps are enough for them to not be able to connect my DNA data back to me. Guess my tinfoil hat worked out in this case!
Re:23andMe to share customer gene data with GlaxoSmithKline ... by markdown on Tuesday December 17, 2019 @06:24PM (#21820117)
That works until a close relative hands over their DNA to 23andMe using their real name.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by trianglem on Friday December 20, 2019 @03:30AM (#21842516)
Never considered this but sadly you’re right.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by bjornjaja on Tuesday December 17, 2019 @02:15PM (#21817477)
Look at what China is doing with peoples DNA—it’s creepy to imagine what the possible outcomes will be with machine learning etc.

Meanwhile I submitted my DNA to ancestry and learned interesting things about my family.

Anything may be used for good or evil.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by coleifer on Tuesday December 17, 2019 @08:36PM (#21820957)
Nice advertisement / damage control.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by laurencerowe on Wednesday December 18, 2019 @02:02AM (#21822554)
> I knew that $99 was not enough to pay for the processing, storage and hosting of my data.

Genotyping is not full sequencing. The files produced are not that large. According to this press release volume pricing is below $40 / sample. https://www.businesswire.com/news/home/20160616005665/en/Ill...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by shripadk on Tuesday December 17, 2019 @01:50PM (#21817131)
> Guess what, my maternal granddad had Parkinson's disease > Just think of what we could do if we could easily treat Alzheimer's or other age related disorders

If only scientists focused their research on Medical Cannabis which is time and again showing positive results on plenty of patients afflicted with Alzheimer's and Parkinson's. My grandpa had Parkinson's too. I wish I or my family knew of Medical Cannabis and the positive effects of CBD back then. It makes me angry that this naturally occurring plant was banned by the CIA and India followed suit when Cannabis (called Vijaya in Sanskrit) was used in Ayurveda for thousands of years. We discarded a medicine that was working perfectly fine for chemicals made artificially by Big Pharma. Now people have no choice and have to resort to going for allopathy when an alternative natural medicine exists but would invite prison time if you use it. No one would dare to break the law. And when accompanied by social stigma in using it you have this fine concoction of guilt for breaking the law and anger, sadness at the sheer ignorance of society.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Antoninus on Wednesday December 18, 2019 @12:42AM (#21822163)
These are my sentiments as well. My wife and I did this before our first child. The data is kept in both a secure server and physical thumb drive with reserved domains, personal email adress with their legal names. I wish I had this type of data growing up, I’m sure I would have at least eaten better. All I got was, grandpa died of a heart attack and grandma died of cancer. Hopefully the kids find it useful.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by amiga_500 on Tuesday December 17, 2019 @07:32PM (#21820648)
What if GSK share this with a health insurance company who want it "for research" and you then cannot get insurance?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by kilo_bravo_3 on Tuesday December 17, 2019 @02:31PM (#21817693)
We are on the verge of a future where automated systems trawl through exabytes of genetic data, lazily analyzing it and spitting out promising results for further, focused, research.

The first steps are being taken today with similar systems for automated drug discovery, and the same amount of effort should be thrown into genetic research.

Not only do I want my DNA in a database making up a genetic version of DigitalCorpora.org, freely available to researchers (commercial and non-profit alike), I also want it available to law enforcement so that when a familial match pops up for a sample in a rape kit or crime scene they can catch the person.

If a critical mass of genetic information could be gathered and sufficient computing power thrown at it, live-saving discoveries could become so routine they aren't even reported on anymore.

I am excited, too.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by thedudeabides5 on Wednesday December 18, 2019 @01:34AM (#21822390)
Know someone who's trying to do this for rape kits, and a couple overzealous state AGs are trying to shut them down (unsuccessfully mind you).

Funny we don't see any subpoenas here while a private company openly trumphs monetizing your DNA data, but threaten the govt 'process' and whamo! lawyers out the wazoo

Re:23andMe to share customer gene data with GlaxoSmithKline ... by gowld on Wednesday December 18, 2019 @12:55AM (#21822237)
It can also jail you for a crime you didn't commit.

amp.theatlantic.com/amp/article/408709/

Or otherwise criminalize your existence https://en.wikipedia.org/wiki/One-drop_rule

Re:23andMe to share customer gene data with GlaxoSmithKline ... by jariel on Tuesday December 17, 2019 @07:03PM (#21820436)
"I knew that $99 was not enough to pay for the processing, storage and hosting of my data."

Sure it is. Definitely the 'hosting and storage' part, which they wouldn't need to do if you weren't the product.

Though there are issues with privacy, I think we should remember that there's a lot of good that can come with this if cures are made available.

It's a really weird route that capitalism has forged on this one. It'd be nice to see public agencies get their act together on these kinds of things. Imagine if a university were able to do this - and all the data were made public to any researcher, properly anonymised.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by throwawaybbb on Wednesday December 18, 2019 @12:32AM (#21822121)
I hope you enjoy being uninsurable for Parkinson's in the future.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by NotSammyHagar on Wednesday December 18, 2019 @04:08AM (#21823131)
My grandfather had parkinson, I have wondered about all this genetic testing. I almost bought those kits when they were alive. I was worried about future negatives, never imagined the law enforcement 'find relatives' thing that happens now.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by paggle on Tuesday December 17, 2019 @02:12PM (#21817447)
You knew all that stuff, great. What about the people who didn’t?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by themagician on Tuesday December 17, 2019 @01:03PM (#21816470)
Same here, G2019S brother.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @11:24AM (#21815106)
You are glad a 3rd party is selling your DNA data to a pharmaco giant without express consent because your relative has a disease?

What?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by jryan49 on Tuesday December 17, 2019 @11:36AM (#21815262)
"Wojcicki stressed that all customers involved had agreed to let their DNA be used for medical research when they signed up for the tests."

I've used 23andme and it's VERY clear when you choose to share or not share your DNA.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @11:39AM (#21815295)
Yes but no.

https://time.com/5349896/23andme-glaxo-smith-kline/

While 23andMe has technically adhered to the original terms of service, they've been sharing your data without your consent with their new parent firms like pharma giant GSK (the same one described in this article) which purchased partial ownership of the company and therefore ownership of the data. You see, giving data to your parent firm is not technically giving data to a third party. This was the business model all along. The 'customers' were the product, and the real customers were pharmaco.

Getting the products (you) to pay for the cost of their own sequencing so the data is effectively free was a stroke of genius. Not only are you giving away incredibly valuable data about yourself only a tiny fraction of which is returned back to you in the form of a report, you're paying for the cost to collect it. It's brilliant.

You've been duped by the dupe that everyone saw coming.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by ailideex on Tuesday December 17, 2019 @12:40PM (#21816144)
I don't see how that article supports the claim that you are making. From the article

> A 23andMe spokesperson told TIME that data privacy is a “top priority” for the company, emphasizing that customer data isn’t used in research without consent, and that GlaxoSmithKline will only receive “summary statistics from analyses 23andMe conducts so that no single individual can be identified.”

Also, if I buy some shares in Amazon I don't get have all their client data.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by take_a_breath on Tuesday December 17, 2019 @02:04PM (#21817336)
Amazon is a publicly traded company. How does that compare to 23andMe?

There are obvious loopholes to the statement “no single individual can be identified”.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by ailideex on Tuesday December 17, 2019 @02:59PM (#21818055)
Shareholders are still shareholders even if the company is not publicly traded/listed. GSK is a shareholder of 23andMe - not it's parent company. 23andMe is not a subsidiary of GSK. GSK does not even own a majority share in 23andMe:

https://www.gsk.com/media/5349/annual-report-2018.pdf

> 23andMe in which the Group holds 14.5%.

You can also find a list of subsidiaries of GSK in there and you will note that 23andMe is not listed among them.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by take_a_breath on Tuesday December 17, 2019 @04:55PM (#21819358)
GSK invested $300 million into 23andMe and created an exclusive collaboration agreement [1]. To be clear, these things happened together, one doesn't exist without the other.

If a publicly traded-company has more than 5% of outstanding shares owned by a single entity, they have to file an SEC Form 13D. This is a typical cut-off to indicate an activist investor [2]. Far less than the 14.5% GSK owns. Without knowing who owns the other 85.5% of 23andMe (or visibility into their board and voting structure), we have no idea who controls the company.

You would need to spend about $44 billion to own 5%, or 24.8 million shares, of Amazon. I'm still not clear on how GSK's purchase of 14.5% of 23andMe along with the exclusive agreement that came with it is the same as buying a single share of Amazon stock.

[1] https://www.cnbc.com/2018/07/24/glaxosmithkline-23andme-team...

[2]https://www.investopedia.com/terms/s/schedule13d.asp

Re:23andMe to share customer gene data with GlaxoSmithKline ... by ailideex on Wednesday December 18, 2019 @01:47AM (#21822462)
> To be clear, these things happened together, one doesn't exist without the other.

Buying 14.5% of a company does not come with an automatic collaboration agreement nor would a collaboration agreement come with 14.5% of a company's stock unless there is specific terms for that in some contract which establishes both. And there very well may have been - but both a collaboration agreement and 14.5% ownership can exists without such a contract.

> I'm still not clear on how GSK's purchase of 14.5% of 23andMe along with the exclusive agreement that came with it is the same as buying a single share of Amazon stock.

The argument that was made and that I was responding to was that GSK is 23andMe's parent firm and therefore not legally a 3rd party ... and I'm not sure how I much clearer I can say a shareholder is a shareholder.

If you want to argue that the exclusive collaboration agreement (which is not the same thing as 14.5% ownership) somehow defeats 23andMe's privacy policy then please, argue for it. Maybe it does - but you have not done anything more than allude to it doing so.

> You would need to spend about $44 billion to own 5%, or 24.8 million shares, of Amazon.

And spending that much will not entitle me to an exclusive collaboration agreement with Amazon nor will it make me somehow not a 3rd party of Amazon and therefore allow Amazon to give me all their client data without violating any privacy policies as the person I was responding to claimed.

> Without knowing who owns the other 85.5% of 23andMe (or visibility into their board and voting structure), we have no idea who controls the company.

We don't - but board members and owners are not the same as parent companies and I don't see how that somehow defeats their privacy policy either but if you think it can please clarify.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by take_a_breath on Wednesday December 18, 2019 @10:50AM (#21826048)
And I was responding to this comment: "if I buy some shares in Amazon I don't get have all their client data."

The point is that GSK wouldn't have invested $300 million without the exclusive collaboration agreement. That is why it's different than buying a publicly traded stock. GSK is not just a random shareholder, they are a significant owner (may even have board seats) with an exclusive collaboration agreement. You are splitting those things up to make your argument, but they are linked together.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by mywittyname on Tuesday December 17, 2019 @11:46AM (#21815381)
> You've been duped by the dupe that everyone saw coming.

Not only that, this is one of the benevolent aspects of 23&Me that people saw coming. It's only a matter of time before this information trickles to insurance companies.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @11:51AM (#21815452)
But wait, it gets better. The data is now permanently out there which means it's only a question of time until it leaks to insurance companies and bad actors, but the data is not only about the individual who submitted their DNA but everyone related to them.

I'm sure GP's children will love them for selling out their data to future employers and insurers.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by chr1 on Tuesday December 17, 2019 @12:45PM (#21816225)
This would be a concern if DNA was something secret like a password, but it isn't, it falls off you all the time in the form of hair and skin cells, so if there was something valuable in your DNA, your employers could get it easily anyway. And if your DNA was useful to insurers you would pay yourself for them to get it, because knowing that your risk of dying from certain disease is higher is also required for preventing that.

In general trying to keep DNA secret to prevent discrimination is a losing game, a better strategy is preventing discrimination itself, which we already have to do for DNA variations that have visible manifestation. Moreover if the number of people who need protection from discrimination increases, we'll get better at preventing it, which would be useful for the people who are being discriminated now.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Faark on Tuesday December 17, 2019 @04:42PM (#21819206)
> your employers could get it easily anyway

I really hope that would be illegal here in the EU. It being physically possible (or even easy) doesn't make it okay. Not having the dataset easily available is one safety layer to prevent discrimination. No, it sadly doesn't help in all cases. Its unlikely there will ever be something that can, unless maybe you believe in perfectly implemented government policy reeducating us or controlling our behavior.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Tuesday December 17, 2019 @12:56PM (#21816378)
I'm curious what "bad actors" you imagine with a DNA dataset. Targeted viral agents to hunt and kill only shadowgovt's? If someone wanted to do that, raiding my trash for a half-eaten sandwich is a lot easier way to get the data they want then hoping I upload it to 23andme.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by vengefulduck on Tuesday December 17, 2019 @02:42PM (#21817818)
I think they were probably referring to the more mundane use of insurance companies buying the data and raising premiums for people with genetic risk factors. Which IMO seems very plausible.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Tuesday December 17, 2019 @03:00PM (#21818067)
It's not impossible, but if it happens, it'll be a hell of a lawsuit. That scenario is specifically carved out as unacceptable in US law.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by LunaSea on Wednesday December 18, 2019 @09:18AM (#21825047)
And we know that no law going against the citizen's own interests ever passed.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @10:04AM (#21825525)
Absolutism doesn't really help in crafting good policy. The threat that bad things could possibly, maybe happen isn't a good reason to stop chasing disease cures.

If we knew the ways vaccination programs would be abused, should we have refrained from inoculating so much of the world against polio?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by LunaSea on Wednesday December 18, 2019 @12:00PM (#21826838)
It absolutely is and it's also the reason the FDA has a process you have to follow before doing human testing before potentially killing people with a new treatment you're trying to develop.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @01:39PM (#21827818)
Yes, exactly. There's a process to follow to minimize risk in human testing. Human testing isn't categorically banned.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by LunaSea on Wednesday December 18, 2019 @02:23PM (#21828300)
Correct, because we thought about the cost and risk of early human trials. Which isn't the case here. You're happy to forego any protection of the people involved.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @04:45PM (#21829795)
I think the case is that people have put quite a bit of thought into costs and risks of big-data aggregation of DNA and come to different conclusions on what risks are realistic and what the consequences of those risks are.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by LunaSea on Wednesday December 18, 2019 @06:10PM (#21830437)
They clearly haven't since they didn't even bother asking their users.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Wednesday December 18, 2019 @06:21PM (#21830522)
It would be hard for them to be more clear about it.

https://www.23andme.com/about/consent/

"Which of my personal information is used for research?"

"Your genetic data and any other personal information you enter into the website, except for your Registration Information (name, contact information, and credit card information), may be analyzed in the research."

It really seems people are complaining because 23andme didn't demand they sign a consent for something they had already explicitly signed a consent to. I, for one, assumed large third-party pharmaceutical companies would have access to the data when I volunteered it. Is there significant risk people misunderstood that? How?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by pdkl95 on Tuesday December 17, 2019 @07:44PM (#21820699)
https://www.youtube.com/watch?v=HKQDSgBHPfY

DEF CON 25 - John Sotos

"Genetic Diseases to Guide Digital Hacks of the Human Genome"

Re:23andMe to share customer gene data with GlaxoSmithKline ... by kube-system on Tuesday December 17, 2019 @12:26PM (#21815932)
US health insurers cannot even possess genetic information for underwriting purposes.

https://en.m.wikipedia.org/wiki/Genetic_Information_Nondiscr...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @12:35PM (#21816082)
You have no idea how many ways there are to adhere to the letter of that law while ignoring the intent. There are entire multinational businesses built specifically to facilitate these kinds of data exchanges while keeping it technically legal.

The health insurer doesn't need the genome. It just needs a number from 1 to 10 from a 'de-identified' source to multiply their scores by.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by kube-system on Tuesday December 17, 2019 @12:52PM (#21816315)
Fair, but they still can't rate my plan with that number.

ACA plan premiums can only be set based on 5 factors: age, location, tobacco use, individual vs. family enrollment, and plan.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Techonomicon on Tuesday December 17, 2019 @01:47PM (#21817097)
Sure, for now. We would all be naiive to believe that insurance companies wouldn't lobby to be able to use other such information continually if they had it until they can use it to charge you more.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by sib on Tuesday December 17, 2019 @07:22PM (#21820567)
Such a strange concept that we say that insurance can't be rated according to significant risk factors.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by kube-system on Tuesday December 17, 2019 @10:38PM (#21821544)
The state of health insurance in the US would be better described as a "private social health benefit program".

Insurance is effective at protecting people from uncertain financial risks, but the demands of the public have gradually changed the function of health insurance to include many things outside of that.

The question was never "what functions do insurance companies do efficiently?", the question has always been "what health benefits do people deserve?". Unfortunately, these questions have different answers.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by heavyset_go on Tuesday December 17, 2019 @02:25PM (#21817616)
Life insurance, disability insurance and long-term care insurance providers can use genetic information to deny coverage[1].

[1] https://www.npr.org/sections/health-shots/2018/08/07/6360262...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by matz1 on Tuesday December 17, 2019 @10:55PM (#21821622)
Yes, there are saying information want to be free. These data should eventually be public anyway, yes including to insurance company. The solution should be even more transparency, rather than privacy. The sooner we embrace and adapt, the better.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by jryan49 on Tuesday December 17, 2019 @11:47AM (#21815393)
The article says they are just using de-identified, summary data, what's the problem?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @11:57AM (#21815528)
Where to start. I could write an entire paper about this.

It's incredibly difficult to truly de-identify data and it's incredibly easy to re-identify it. Making data truly anonymous usually also neuters the data for any kind of predictive models.

23andMe is selling either straight up raw data (which is totally allowed under the investment terms) or tightly grouped 'summary' data which can be trivially re-identified. If they were selling actually anonymous data it would be worth nothing because it would yield no predictions.

Disclaimer: I work in ML/predictive analytics. 'anonymous data' is a marketing term for trivially reidentifiable data. If the data is truly anonymous then its predictive power tends towards 0 as does its market price. You don't think GSK dropped 300 mil on mostly useless data do you?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by streb-lo on Tuesday December 17, 2019 @03:11PM (#21818198)
Why do we care?

Trying to keep genetic identity anonymous is security through obscurity. You have shed thousands of skin cells in the time it took for you to read this. If people want your DNA it's trivial to collect -- and will only get easier and more common.

A better use of our time is to address the ramifications of public DNA and prevent it from being misused.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Real_S on Tuesday December 17, 2019 @03:59PM (#21818778)
I can send someone to follow you around to see where you go. Therefore, you do not mind if your GPS data is public?

Now compare the cost of hacking into a database to the cost of obtaining millions of genomes by physically taking genetic material and then sequencing it. Then consider that your DNA is yours for the rest of your life.

Simply because data can be obtained by some means does not make protecting that data useless.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by streb-lo on Tuesday December 17, 2019 @04:09PM (#21818866)
No, that's a bad analogy. Following someone is manpower intensive. A better analogy would be sending someone to observe your hair color -- do you mind if that's public?

As the value of DNA increases, people will collect it. Restaurants, washrooms, your employer, airlines, Uber etc. all could have trivially easy access to your DNA if they choose to.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @06:46PM (#21820304)
It's illegal to follow someone around to collect their location data. It's a pretty good analogy.

Just because there is 'trivial' access to certain attributes of people doesn't mean that it's legal to capture those attributes, and even if you do capture them, they're worthless on the legal market. E.g. see SF ban on facial recognition.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by streb-lo on Wednesday December 18, 2019 @12:49AM (#21822206)
Like you say, legal barriers can only prevent things that rely on a legal market, like insurance carriers from discriminating against people's genetic makeup. Against genetic weaponization and other state-sponsored uses it would be a bit like banning nuclear bombs -- a great idea for everyone but a foolish one for each individual state.

And that's only if such legal barriers are even constructed which I'm not sure they will be. Look how the privacy battle has turned out thus far.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by JoeAltmaier on Tuesday December 17, 2019 @06:48PM (#21820324)
Really? Public surveillance is explicitly allowed without warrant.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by allovernow on Tuesday December 17, 2019 @12:24PM (#21815909)
Why, in 2019, would you trust such a statement from a faceless corporate behemoth?

Why, after the consistent abuses and lack of accountability across the corporate sphere, would you place any faith in a business's claim that they're just leaving what probably already amounts to billions of dollars of value on the table when there is effectively no penalty for covertly extracting said value at the cost of customer privacy?

Why, after a decade+ of security breaches and poor data handling practices, would you trust a financially motivated, publicly traded company to properly anonimize data?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by 1024core on Tuesday December 17, 2019 @12:02PM (#21815601)
Maybe you've not been paying attention to the news, but it is very easy to re-identify people with their genetic data.

[1] https://www.telegraph.co.uk/news/2018/04/27/golden-state-kil...

[2] https://www.latimes.com/california/story/2019-11-24/law-enfo...

[3] https://www.usatoday.com/story/tech/nation-now/2018/04/27/an...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by jb775 on Tuesday December 17, 2019 @02:40PM (#21817793)
Computer algorithm can identify 99.98 percent of Americans from almost any available data set with as few as 15 attributes, such as gender, ZIP code or marital status.

https://www.nytimes.com/2019/07/23/health/data-privacy-prote...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by arrosenberg on Tuesday December 17, 2019 @02:10PM (#21817418)
Easy to say, hard to do. HIPAA isn't enforced nearly as frequently as it should be.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by JohnFen on Tuesday December 17, 2019 @05:00PM (#21819402)
Hmmm.

I'm going to have to investigate this more thoroughly. If it's true, then I'll delete my data at 23&me (and hope that data deletion actually does what it says).

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dahinds on Tuesday December 17, 2019 @11:11PM (#21821700)
This is not what the article says, and it is false. No customer data has been shared with GSK.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by freeflight on Tuesday December 17, 2019 @12:20PM (#21815834)
Do they actually actively ask for a choice during the process or is it rather a right they reserve for themselves, buried in hundreds of pages of ToS?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by jryan49 on Tuesday December 17, 2019 @12:31PM (#21816019)
Yes, it's directly asked on it's own page during the sign up processs, with lots of details. At least when I signed up.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Tuesday December 17, 2019 @12:54PM (#21816351)
I can't answer for the original poster, but were it me, yes.

I'm certainly not doing anything to cure that disease. Strict privacy advocates aren't doing something to cure that disease (I guess they might be, but how would I know, they don't talk about themselves much ;) ).

I value a cure for Parkinson's more than I value my privacy. If selling the DNA I provided as part of a research dataset (that I provided without knowing who would be doing the research, but knowing it'd be someone because that's how research works) cures Parkinson's, I'm on board.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by tomcooks on Tuesday December 17, 2019 @04:06PM (#21818837)
> If selling the DNA I provided as part of a research dataset (that I provided without knowing who would be doing the research, but knowing it'd be someone because that's how research works) cures Parkinson's, I'm on board.

And that's the best case scenario, the worst case scenario is that your data is used to increase your insurance and healthcare rates.

Moreover, it normalises crappy corporate behaviour.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by taneq on Tuesday December 17, 2019 @02:22PM (#21817582)
Hey and that's cool but you can't make that call for other people. That's the whole thing about consent and why it's important.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Tuesday December 17, 2019 @03:02PM (#21818094)
But the question was express consent. I'm willing to trust 23andme to pass the data to whatever research team has the resources to make progress (that was certainly my intent, at least, in signing over consent to them in the first place; I don't know enough about medical research to have an opinion on the details of who does the work, and I delegate that responsibility to 23andme).
Re:23andMe to share customer gene data with GlaxoSmithKline ... by hedvig on Tuesday December 17, 2019 @01:34PM (#21816909)
And what percentage of your net-worth and/or your insurers bearance would you be willing to commit to the yearly treatment they'll come up with (not a cure)?
Re:23andMe to share customer gene data with GlaxoSmithKline ... by mortenjorck on Tuesday December 17, 2019 @02:53PM (#21817965)
The idea that pharmaceutical companies focus on treatment at the expense of cures is inaccurate. Not because they’ve decided to put the greater good ahead of profits, but because they realized they could price breakthrough cures to match the customer LTV of chronic treatments.

Novartis recently won approval for a cure to a rare genetic disorder, priced at two million dollars: https://www.reuters.com/article/us-novartis-genetherapy/nova...

Re:23andMe to share customer gene data with GlaxoSmithKline ... by pertymcpert on Tuesday December 17, 2019 @01:40PM (#21817004)
I guess everything because Parkinsons is a catastrophic illness from a quality of life perspective.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by shadowgovt on Tuesday December 17, 2019 @02:23PM (#21817600)
(a) I have no reason to believe at this point, a priori, that Parkinson's isn't curable (Clarke's First Law)

(b) To address that issue, I vote for politicians who advocate for radically restructuring how healthcare is paid for in the US to minimize incentives to gouge unlucky individuals

Re:23andMe to share customer gene data with GlaxoSmithKline ... by danudey on Tuesday December 17, 2019 @01:40PM (#21817007)
Personally, I can't wait for the inevitable medical breakthroughs discovered through the service that we paid for, that GSK will sell back to us for thousands of dollars per treatment.

There's something so purely dystopian about paying a company to collect our genomic data, which then helps to create medical breakthroughs that none of us will be able to afford.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by downvoted on Tuesday December 17, 2019 @03:43PM (#21818589)
And though the idea is tricky, commercializing our genome is no longer about "hey, the next R&D breakthrough will come from your genome." It's about making sure that the first humans to create such breakthroughs can get rich off the money it pays for them.

This is why it's so important that companies refrain from selling our genomes to biotech companies.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by trixie_ on Tuesday December 17, 2019 @08:12PM (#21820836)
Wouldn't you be paying for all the R&D that was required after using the genetic info to develop a treatment.

If the treatment ends up costing $100k, the genetic info you provided resulted in a discount from infinite dollars to an actual finite amount.

That's a pretty big discount.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by whatitdobooboo on Tuesday December 17, 2019 @11:30AM (#21815184)
I would bet its more secure and scrutinized than your local doctors' office handling of your data
Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @11:31AM (#21815200)
My doctor doesn't have my genome. And if they did it would be covered by HIPAA and untouchable by 3rd parties.

I'm shocked that it needs to be spelled out on HN, but companies like 23andMe are the epitome of 'you are the product'.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by toomuchtodo on Tuesday December 17, 2019 @11:35AM (#21815244)
I don't share my genome with my doctor because they don't need it (yet; also, EPIC and Apple Health don't really support OAuth to 23andme for grabbing the raw file). I have used 23andme, as well as my entire family, and have opted us all into their research. We make this choice voluntarily and in an informed manner. I am willing to trade genetic privacy (which is tenuous at best, I leave DNA everywhere as a human) for progress. Same reason my genome (as well as a sibling's) is public on Harvard's Personal Genome Project. I have a shelf life, but research lives on.

I don't believe myself to have been duped. I've made concessions based on priorities. Would I prefer this work be done, publicly funded, by the NIH and other non-profit researchers? Absolutely. Am I willing to wait for perfection? Absolutely not. Federal law currently protects your DNA data from employers and insurance companies. If you find that to be insufficient, run for office.

Disclaimer: Interviewed and was offered a role at 23andme a lifetime ago (2011), no other affiliation besides being a satisfied customer.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @12:17PM (#21815800)
If you want progress give your genome to your local uni so they can pass it on to researchers, not to a comic book badguy profit seeking pharma giant like GSK who will totally sue the shit out of anyone else who uses it without their go-ahead.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by toomuchtodo on Tuesday December 17, 2019 @12:20PM (#21815853)
I want results, not someone who has to churn out papers to meet their academic requirements. Go where the resources are.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @12:32PM (#21816025)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421770/

Yeah GSK is definitely where the resources are. To circumvent regulations and laws.

Fuck actual research right?

Re:23andMe to share customer gene data with GlaxoSmithKline ... by toomuchtodo on Tuesday December 17, 2019 @12:35PM (#21816079)
See my comment above where I contributed my DNA to Harvard’s genome project. I approve all requests to use it in partner studies. Not sure what else you’re expecting, but my opinion is that your expectations are unrealistic.

If you don’t like the law, fix the law. If you have evidence a drug company or data provider violated the law, report them to your attorney general.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by chr1 on Tuesday December 17, 2019 @12:53PM (#21816332)
Which university wants a genome for research? I would gladly give it, but don't know anyone who'd want my genome.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by darkpicnic on Tuesday December 17, 2019 @12:21PM (#21815861)
That's incorrect. HIPAA compliance only requires consent between patient and provider. Provider can choose to share that data with other providers. This is how Google purchased medical records by partnering with Ascension.

If you are covered under 42 CFR Part 2, then it would not be allowed because the patient has to give consent to ALL parties.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by missosoup on Tuesday December 17, 2019 @12:27PM (#21815946)
> Provider can choose to share that data with other providers

Not without express consent. The default is 0 hops. Same rules applies for banking info.

You want to share with someone else? You have to ask for consent again. A lot of people did unknowingly sign up to have their data shared like you say though, which I think is a regulatory failure more than anything else.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by JohnFen on Tuesday December 17, 2019 @05:06PM (#21819461)
In the US, HIPAA allows your medical data to be shared without your express consent as long as certain conditions are met. Generally, they are that the data must be used to help your provider meet a legitimate medical or business need, and they have to have a contract with the entities they share with that constrains their use of that data.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by darkpicnic on Wednesday December 18, 2019 @03:15PM (#21828931)
HIPAA compliance has a lot of ambiguity. You are correct if, say, your employer requested medical records from your doctor. However, any entity that works with your provider that is facilitating its business can still get your data without your consent.

JohnFen's comment is correct. This is why 42 CFR Part 2 was created; HIPAA was too loose with patient data.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by Bombthecat on Tuesday December 17, 2019 @04:59PM (#21819392)
Until the pill costs one million and you get nothing, or even, if you need it you can't afford it.
Re:23andMe to share customer gene data with GlaxoSmithKline ... by goatinaboat on Tuesday December 17, 2019 @06:55PM (#21820379)
Guess what, my maternal granddad had Parkinson's disease. I hope to god the do something with our data

Guess what, they will sell it to insurance companies who will gouge you for the rest of your life. That was always the endgame.

Re:23andMe to share customer gene data with GlaxoSmithKline ... by peteretep on Tuesday December 17, 2019 @08:50PM (#21821025)
> they will sell it to insurance companies who will gouge you for the rest of your life

Where do you live that this would be legal?